Related Experiment Video

Updated: Aug 24, 2026

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
10:01

Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

Published on: October 17, 2018

Yellow fever vaccine is safe and effective in HIV-infected patients

Pierre Tattevin, Agnès Geremy Depatureaux, Jean Marc Chapplain

    AIDS (London, England)
    |April 13, 2004
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
    08:13

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

    Published on: January 20, 2019

    A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
    07:06

    A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum

    Published on: April 10, 2018

    Related Experiment Videos

    Last Updated: Aug 24, 2026

    Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice
    10:01

    Evaluation of Zika Virus-specific T-cell Responses in Immunoprivileged Organs of Infected Ifnar1-/- Mice

    Published on: October 17, 2018

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination
    08:13

    Optimized Interferon-gamma ELISpot Assay to Measure T Cell Responses in the Guinea Pig Model after Vaccination

    Published on: January 20, 2019

    A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum
    07:06

    A Simple Flow Cytometry Based Assay to Determine In Vitro Antibody Dependent Enhancement of Dengue Virus Using Zika Virus Convalescent Serum

    Published on: April 10, 2018

    Related Concept Videos

    Yellow Fever01:18

    Yellow Fever

    Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...

    Articles linked to this work by shared authors, journal, and citation graph.

    Evolution of Untreated Anal High-grade Squamous Intraepithelial Lesions in High-risk Men: A Prospective 5-year Clinical Follow-up in the ANRS-EP57-APACHES study.

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

    Outcome of guided persistent fistula as a salvage procedure in patients with chronic periprosthetic joint infection.

    International orthopaedics·2026

    Streptococcus agalactiae bone and joint infection: a multicentre observational study 2014-23.

    The Journal of infection·2026

    Clinical features and outcomes of fungal bone and joint infections in Western France.

    International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

    Machine learning prediction of weight gain after antiretroviral therapy initiation in people with HIV: Insights from a large french real-world cohort.

    PloS one·2026

    Sexual health indicators among young adults living with perinatally-acquired HIV in france, a gender-stratified comparison with their peers in the general population.

    BMC public health·2025

    Retention in care: is it still a clinically useful indicator for monitoring long-term engagement in HIV care in the treat-all era?

    AIDS (London, England)·2026

    Cancer incidence and risk factors among people with HIV in REPRIEVE.

    AIDS (London, England)·2026

    Effects of semaglutide on subclinical cardiovascular health in people with HIV.

    AIDS (London, England)·2026

    Antiretroviral therapy regimens initiated during pregnancy and risks of adverse perinatal outcomes.

    AIDS (London, England)·2026

    Does where you live matter? Rurality and 30-day hospital readmission among people with HIV.

    AIDS (London, England)·2026

    Circulating markers of organ damage associate with COPD in people with HIV: an exploratory proteomic analysis.

    AIDS (London, England)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us